| 67.35 Real-Time Quote |  -0.50 / -0.74%Today’s Change | 52.90 Today|||52-Week Range 75.78 | -4.11% Year-to-Date |
| Varian Wins 510(k) for X-Ray System - Analyst Blog May 28 / Zacks.com | Accuray Presents Positive Data - Analyst Blog May 24 / Zacks.com |
| 1 Reason Varian Medical Systems May Be Headed for a Slowdown May 28 / MotleyFool.com |
| Previous close | 67.85 |
| Today’s open | 67.84 |
| Day’s range | 67.27 - 67.99 |
| Volume | 61,585 |
| Average volume (3 months) | 788,598 |
| Market cap | $7.4B |
| Dividend yield | -- |
| Earnings growth (last year) | +11.90% |
| Earnings growth (this year) | +9.19% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | +8.04% |
| P/E ratio | 17.3 |
| Price/Sales | 2.39 |
| Price/Book | 4.92 |
| Today’s change | Today’s % change | |
|---|---|---|
| RMDResMed Inc | -1.13 | -2.42% |
| TFXTeleflex Inc | +0.09 | +0.12% |
| STJSt. Jude Medical Inc | -0.14 | -0.33% |
| THORThoratec Corp | -0.07 | -0.23% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $1.01 |
| Annual revenue (last year) | $2.8B |
| Annual profit (last year) | $427.0M |
| Net profit margin | 15.22% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Dow R. Wilson, MBA |
Chief Financial Officer & Executive Vice President Elisha W. Finney, MBA |
Corporate headquarters Palo Alto, California |
.
